{
    "root": "352d8ab7-2e21-869d-e063-6294a90ab91f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "IRBESARTAN",
    "value": "20250515",
    "ingredients": [
        {
            "name": "CARBOXYMETHYLCELLULOSE CALCIUM",
            "code": "UTY7PDF93L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "IRBESARTAN",
            "code": "J0E2756Z7N",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5959"
        }
    ],
    "indications": {
        "text": "irbesartan angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) treatment diabetic nephropathy hypertensive patients type 2 diabetes , elevated serum creatinine , proteinuria . ( 1.2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            },
            {
                "text": "type 2 diabetes (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            },
            {
                "text": "proteinuria (DOID:576)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_576"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "indication dose hypertension ( 2.2 ) 150 300 mg daily diabetic nephropathy ( 2.3 ) 300 mg daily",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "irbesartan tablets , usp 75 mg available white off-white , round , flat beveled edge tablets , debossed \u201c ce \u201d one side \u201c 283 \u201d side . bottles 30 tablets \u2013 ndc 62135-976-30 bottles 90 tablets \u2013 ndc 62135-976-90 irbesartan tablets , usp 150 mg available white off-white , round , flat beveled edge tablets , debossed \u201c ce \u201d one side \u201c 284 \u201d side . bottles 30 tablets \u2013 ndc 62135-977-30 bottle 90 tablets \u2013 ndc 62135-977-90 irbesartan tablets , usp 300 mg available white off-white , oblong , standard concave tablets , debossed \u201c ce \u201d one side \u201c 285 \u201d side . bottles 30 tablets \u2013 ndc 62135-978-30 bottle 90 tablets \u2013 ndc 62135-978-90 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "irbesartan tablets contraindicated patients hypersensitive component product . coadminister aliskiren irbesartan tablets patients diabetes .",
    "indications_original": "Irbesartan is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 )",
    "contraindications_original": "Indication Dose Hypertension ( 2.2 ) 150 to 300 mg once daily Diabetic Nephropathy ( 2.3 ) 300 mg once daily",
    "warningsAndPrecautions_original": "Irbesartan Tablets, USP 75 mg are available as white to off-white, round, flat beveled edge tablets, debossed with\n \n  \u201cCE\u201don one side and\n \n  \u201c283\u201don the other side.\n\n \n                  Bottles of 30 tablets \u2013 NDC 62135-976-30\n                  Bottles of 90 tablets \u2013 NDC 62135-976-90\n                  Irbesartan Tablets, USP 150 mg are available as white to off-white, round, flat beveled edge tablets, debossed with\n \n  \u201cCE\u201don one side and\n \n  \u201c284\u201don the other side.\n\n \n                  Bottles of 30 tablets \u2013 NDC 62135-977-30\n                  Bottle of 90 tablets \u2013 NDC 62135-977-90\n                  Irbesartan Tablets, USP 300 mg are available as white to off-white, oblong, standard concave tablets, debossed with\n \n  \u201cCE\u201don one side and\n \n  \u201c285\u201don the other side.\n\n \n                  Bottles of 30 tablets \u2013 NDC 62135-978-30\n                  Bottle of 90 tablets \u2013 NDC 62135-978-90\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Irbesartan tablets are contraindicated in patients who are hypersensitive to any component of this product.\n                  Do not coadminister aliskiren with irbesartan tablets in patients with diabetes.",
    "drug": [
        {
            "name": "IRBESARTAN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5959"
        }
    ]
}